0001104659-21-091356.txt : 20210712 0001104659-21-091356.hdr.sgml : 20210712 20210712205859 ACCESSION NUMBER: 0001104659-21-091356 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210712 DATE AS OF CHANGE: 20210712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horsager Alan M CENTRAL INDEX KEY: 0001871699 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39788 FILM NUMBER: 211086606 MAIL ADDRESS: STREET 1: 1021 N EVERETT STREET CITY: GLENDALE STATE: CA ZIP: 91207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Scopus BioPharma Inc. CENTRAL INDEX KEY: 0001772028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821248020 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: (212) 479-2513 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE, SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: Scopus Biopharma Inc. DATE OF NAME CHANGE: 20190327 3 1 tm2122052d2_3.xml OWNERSHIP DOCUMENT X0206 3 2021-06-25 0 0001772028 Scopus BioPharma Inc. SCPS 0001871699 Horsager Alan M C/O SCOPUS BIOPHARMA, INC., 420 LEXINGTON AVENUE, SUITE 300 NY NY 10170 0 1 0 0 See Remarks Common Stock 118200 D President and CEO of Olimmune (100% Subsidiary) /s/ Alan M. Horsager, Ph.D 2021-07-12